Ministry of Health and Welfare recertified for the 3rd time as an innovative pharmaceutical company (2021.6.20 ~ 2024.6.19)

Approved as Korea's first rosuvastatin oral disintegrating tablet "Suvaro Odi Tablet"

Registered in a European patent, the preparation method of drug-containing sustained release microparticles

Registered in the US patent, the new methods and apparatus for preparing liposomes

Registered in the EU patent, Preparation method of drug-containing sustained biodegradable microparticles

Registered in Germany patent, Preparation method of drug-containing sustained biodegradable microparticles

Registered in the EU patent, the new methods and apparatus for preparing liposomes

Advanced medical technology development project (Ministry of Health and Welfare): Anti-thromobotic combination drug development of Triple mechanism releasing behavior using PRFE Technology (Selected as national project)

Registered in Korea patent, Preparation method of drug-containing sustained release microparticles

Registered in India patent, Pharmaceutical composition comprising metformin and rosuvastatin

Registered in China patent, the new methods and apparatus for preparing liposomes

Registered in Japan patent, Preparation method of drug-containing sustained release microparticles

Registered in Korea patent, Novel derivatives of nucleosides

Acquired preferential sales right of Narco Sublingual Tablet

Acquired preferential sales right of Cossac-L Tablet

Registered in the EU patent, Pharmaceutical composition comprising metformin and rosuvastatin

High-tech medical complex base technology construction project (Ministry of Health and Welfare): Evaluation of the safety and efficacy of long-acting Parkinson's disease medications (Selected as national project)

Registered in Japan patent, Pharmaceutical composition comprising metformin and rosuvastatin

Registered in the US patent, Pharmaceutical composition comprising metformin and rosuvastatin

Registered in Canada patent, the new methods and apparatus for preparing liposomes

Registered in the US, New method for producing imatinib base

Ministry of Health and Welfare recertified for the 2nd time as an innovative pharmaceutical company (2015.6.20 ~ 2018.6.19)

Registered in Japan patent, New method for producing imatinib base

Advanced medical technology development project (Ministry of Health and Welfare)

“Development of pharmaceutical sustained-release combination for the treatment of hyperlipidemia and diabetes” (Selected as a national project)

Registered in Japan patent, the new methods and apparatus for preparing liposomes

Signed a contract with Akorn (USA) for licensing-out and supply in the US market of Prostate cancer treatment using Emulsifier-free SEP Microsphere DDS technology (long-acting injection)

Registered in Korea patent, GM-CSF (Granulocyte Macrophage-Colony Stimulating Factor) composition comprising

Signed a contract with AET (Germany) for Platform Technology Licensing Out and joint research

Registered in Korea patent, the new methods for preparing dutasteride

Registered in China, Technology of Emulsifier-free SEP

Registered in Korea patent, Pharmaceutical composition for treating tuberculosis comprising rifampicin and method for preparing the same

Registered in Vietnam patent, Technology of Emulsifier-free SEP

Registered in Korea patent, composition comprising methylphenidate

Registered in Korea patent, New method for producing imatinib base

Registered in Korea patent, New method for producing imatinib base

Selected as a health and medical research and development project (Ministry of Health and Welfare): Development of sustained-release complex formulation for improving side effects for the treatment of diabetic hyperlipidemia (Selected as national project)

Registered in the UK, Technology of Emulsifier-free SEP

Registered in Korea patent, Self-emulsifying drug delivery system composition comprising dutasteride

Selected as a technology innovation development project of small and medium enterprises (Small and Medium Business Administration) : Emulsifier-free SEP technology Risperidone

Development of Sustained Release Injectable Drugs (Selected as national project)

Registered in the US patent, Technology of Emulsifier-free SEP

Registered in Mexico patent, Technology of Emulsifier-free SEP

Registered in Korea patent, composition comprising Moxifloxacin

Registered in Korea patent, composition comprising Nucleoside derivatives

Registered in Korea patent, technology of SCF (SuperCritical Fluid) Liposome